share_log

AIA Group Ltd Has $179,000 Stock Position in The Clorox Company (NYSE:CLX)

AIA Group Ltd Has $179,000 Stock Position in The Clorox Company (NYSE:CLX)

友邦保險控股有限公司於高樂氏公司(紐約證交所代碼:CLX)擁有 179,000 美元股票頭寸
Financial News Live ·  2023/01/27 12:12

AIA Group Ltd reduced its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 38.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,395 shares of the company's stock after selling 859 shares during the period. AIA Group Ltd's holdings in Clorox were worth $179,000 at the end of the most recent reporting period.

據HoldingsChannel.com報道,友邦保險有限公司在第三季度減持了高樂氏公司(紐約證券交易所代碼:CLX-GET評級)38.1%的股份。該公司在此期間出售了859股後,持有1,395股該公司股票。在最近一次報告期結束時,友邦保險有限公司持有的高樂氏股份價值179,000美元。

Other large investors also recently modified their holdings of the company. Heritage Financial Services LLC acquired a new stake in shares of Clorox during the 2nd quarter worth $30,000. Curi Wealth Management LLC grew its holdings in shares of Clorox by 64.5% during the 2nd quarter. Curi Wealth Management LLC now owns 227 shares of the company's stock worth $32,000 after purchasing an additional 89 shares in the last quarter. Charter Oak Capital Management LLC acquired a new stake in shares of Clorox during the 2nd quarter worth $36,000. Massmutual Trust Co. FSB ADV grew its holdings in shares of Clorox by 65.8% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 252 shares of the company's stock worth $32,000 after purchasing an additional 100 shares in the last quarter. Finally, LS Investment Advisors LLC acquired a new stake in Clorox in the second quarter valued at about $42,000. 79.12% of the stock is owned by institutional investors and hedge funds.

其他大型投資者最近也調整了對該公司的持股。遺產金融服務有限責任公司在第二季度收購了價值3萬美元的高樂氏新股。Curi Wealth Management LLC在第二季度增持了64.5%的高樂氏股票。Curi Wealth Management LLC現在持有227股該公司股票,價值32,000美元,在上個季度又購買了89股。Charge Oak Capital Management LLC在第二季度收購了價值3.6萬美元的高樂氏新股。MassMutual Trust Co.FSB ADV在第三季度增持了65.8%的高樂氏股票。MassMutual Trust Co.FSB ADV現在持有該公司252股股票,價值3.2萬美元,此前該公司在上個季度又購買了100股。最後,LS Investment Advisors LLC在第二季度收購了Clorox的新股份,價值約4.2萬美元。79.12%的股票由機構投資者和對衝基金持有。

Get
到達
Clorox
高樂氏
alerts:
警報:

Clorox Price Performance

高樂氏性價比

Shares of CLX opened at $141.88 on Friday. The company has a market capitalization of $17.51 billion, a price-to-earnings ratio of 43.52, a price-to-earnings-growth ratio of 2.95 and a beta of 0.31. The business has a 50-day moving average of $145.40 and a 200-day moving average of $143.09. The company has a debt-to-equity ratio of 4.99, a current ratio of 0.88 and a quick ratio of 0.50. The Clorox Company has a 1 year low of $120.50 and a 1 year high of $169.16.

上週五,CLX的股價開盤報141.88美元。該公司市值為175.1億美元,市盈率為43.52倍,市盈率為2.95倍,貝塔係數為0.31。該業務的50日移動均線切入位在145.40美元,200日移動均線切入位在143.09美元。該公司的債務權益比為4.99,流動比率為0.88,速動比率為0.50。高樂氏公司的一年低點為120.50美元,一年高位為169.16美元。

Clorox (NYSE:CLX – Get Rating) last issued its earnings results on Tuesday, November 1st. The company reported $0.93 earnings per share for the quarter, topping analysts' consensus estimates of $0.73 by $0.20. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 83.00% and a net margin of 5.75%. As a group, equities research analysts anticipate that The Clorox Company will post 4.12 earnings per share for the current year.
高樂氏(NYSE:CLX-GET Rating)最近一次發佈收益報告是在11月1日(星期二)。該公司公佈本季度每股收益為0.93美元,比分析師普遍預期的0.73美元高出0.20美元。該業務本季度營收為17.4億美元,而市場普遍預期為16.9億美元。高樂氏的股本回報率為83.00%,淨利潤率為5.75%。作為一個整體,股票研究分析師預計,高樂氏公司本年度的每股收益將達到4.12美元。

Clorox Announces Dividend

高樂氏宣佈分紅

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Shareholders of record on Wednesday, January 25th will be issued a $1.18 dividend. The ex-dividend date of this dividend is Tuesday, January 24th. This represents a $4.72 dividend on an annualized basis and a yield of 3.33%. Clorox's payout ratio is currently 144.79%.

該公司最近還宣佈了季度股息,將於2月10日(星期五)支付。1月25日(星期三)登記在冊的股東將獲得1.18美元的股息。本次股息除息日為1月24日(星期二)。這意味着年化股息為4.72美元,收益率為3.33%。高樂氏的派息率目前為144.79。

Wall Street Analyst Weigh In

華爾街分析師也加入進來

CLX has been the topic of several research analyst reports. DA Davidson raised their price objective on Clorox from $124.00 to $155.00 and gave the company a "neutral" rating in a research note on Wednesday, November 2nd. JPMorgan Chase & Co. raised their price objective on Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research note on Friday, January 13th. Evercore ISI initiated coverage on Clorox in a research note on Monday, October 17th. They issued an "underperform" rating on the stock. UBS Group increased their target price on Clorox from $119.00 to $129.00 and gave the company a "sell" rating in a research report on Wednesday, November 2nd. Finally, Morgan Stanley increased their target price on Clorox from $130.00 to $142.00 and gave the company an "equal weight" rating in a research report on Wednesday, November 2nd. Nine equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and a consensus price target of $136.92.

CLX一直是幾份研究分析師報告的主題。11月2日,達戴維森在一份研究報告中將高樂氏的目標價從124.00美元上調至155.00美元,並將該公司的評級定為“中性”。摩根大通將高樂氏的目標價從126.00美元上調至135.00美元,並在1月13日星期五的一份研究報告中給予該公司“減持”評級。Evercore ISI在10月17日星期一的一份研究報告中發起了對Clorox的報道。他們對該股給予了“表現不佳”的評級。瑞銀集團11月2日週三在一份研究報告中將高樂氏目標價從119.00美元上調至129.00美元,並給予該公司“賣出”評級。最後,摩根士丹利將高樂氏目標價從130.00美元上調至142.00美元,並在11月2日(週三)的一份研究報告中給予該公司“同等權重”的評級。9名股票研究分析師對該股的評級為賣出,4名分析師給出了持有評級,一名分析師對該公司發出了買入評級。根據MarketBeat.com的數據,該股目前的平均評級為“減持”,共識目標價為136.92美元。

Clorox Profile

高樂氏簡介

(Get Rating)

(獲取評級)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

高樂氏公司從事消費品和專業產品的製造和營銷。它通過以下業務部門運營:健康和健康、家庭、生活方式和國際。健康和健康部分包括清潔產品、專業產品和維生素、礦物質和補充劑,主要在美國銷售和銷售。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Clorox (CLX)
  • EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
  • Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
  • Shopify Clears Cup-With-Handle Base: Can Momentum Continue?
  • The Future Of E-Commerce: Analysis And New Data
  • Chevron Delights Shareholders with $75 Billion in Share Buybacks
  • 免費獲取StockNews.com關於高樂氏的研究報告
  • 電動汽車和機器人成為增長動力,芯片製造商意法半導體出現缺口
  • 石油服務公司NOV有足夠的能量維持漲勢嗎?
  • Shopify Clears杯柄基地:勢頭還能持續嗎?
  • 電子商務的未來:分析和新數據
  • 雪佛龍以750億美元的股票回購取悦股東

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).

想看看還有哪些對衝基金持有CLX嗎?訪問HoldingsChannel.com,獲取高樂氏公司(紐約證券交易所代碼:CLX-GET評級)的最新13F文件和內幕交易。

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

接受《高樂氏日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Clorox和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論